BIO CEO & Investor Digital Conference 2022 | Biotechnology Innovation Organization | 14 February 2022 | New York Marriott Marquis & Virtual, 1535 Broadway, New York, NY 10036, USA

For more than 20 years, it has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.

For one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

2022 Speakers

Michael Poirier
Chairman & CEO, Qualigen Therapeutics, Inc.

Ofer Sharon, MBA;MD
CEO, OncoHost

Steven Potts, MBA;PhD
Cofounder, CEO & Director, OncoMyx Therapeutics

Steve Worland, PhD
President and CEO, eFFECTOR Therapeutics

James Helliwell, FRCP;MD
CEO, Eupraxia Pharmaceuticals Inc.

Randolf Kerschbaumer
CEO, OncoOne

Molly Harper
Chief Business Officer, Synlogic

David Berry, MD;PhD
Founder, Chief Executive Officer, General Partner, Valo Health; Flagship Pioneering

Sara Nayeem, MD
Partner, Avoro Ventures

Otello Stampacchia, PhD
Managing Director, Omega Funds

Asish Xavier
Vice President, Johnson & Johnson Development Corporation

Martin Welschof
CEO, BioInvent International AB

Anthony Desir
CEO, Moexa Pharmaceuticals Limited

Judy Chou, PhD
CEO and President, AltruBio, Inc.

James Garner, BSc;MA;MBA;MBBS
Chief Executive Officer, Kazia Therapeutics Ltd

James Rolke
CEO, Revelation Biosciences Inc

Dror Harats, MD
Chief Executive Officer, Vascular Biogenics Ltd.

Lillian Chiang, MBA, PhD
CEO, Evrys Bio

Carlos Buesa, PhD
Chief Executive Officer, Oryzon Genomics, S.A.

Tim Clackson
CEO, Theseus Pharmaceuticals

Kate Haviland
Chief Operating Officer, Blueprint Medicines

Michael King Jr.
Managing Director, H.C. Wainwright & Company

John Lubniewski
President & Chief Executive Officer, HTG Molecular Diagnostics, Inc.

Tyler Martin, MD
CEO, Adjuvance Technologies, Inc.

Matthew Gantz
President & CEO, Castle Creek Biosciences, Inc.

Jennifer Chow
CEO and Managing Director, Chimeric Therapeutics

Bradley Burnam
CEO, Turn Therapeutics

Marc Hedrick, MD
President/CEO, Plus Therapeutics

Bonnie Fendrock, MBA;MS
Chief Executive Officer, Cyta Therapeutics

Riccardo Canevari
CEO, Radiopharm Theranostics

Brian Windsor, PhD
Chief Executive Officer, Lung Therapeutics, Inc.

Zhi-Ren Liu
Professor, ProDa BioTech

Darren Ji, MBA;MD;PhD
CEO, Elpiscience Biopharma

Isaac Bright, MD
CEO, RubrYc Therapeutics, Inc.

Sabrina Johnson
CEO, Daré Bioscience

Peter Llewellyn-Davies
CEO, invIOs GmbH

Snehal Patel
CEO, Greenwich LifeSciences, Inc.

Sanjay Shukla, MD;MS
President, CEO, aTyr Pharma, Inc.

David Silberstein, MPH;MPhil;PhD
Chief Operating Officer, BioMimetix JV, LLC

Raphael OGNAR, MBA;MSc
CEO & Co-founder, NKILT Therapeutics Inc.

Michael Davies, MD
CEO & Founder, Carocell Bio

Paul Rennie
CEO, Paradigm Biopharmaceuticals, Paradigm BioPharmaceuticals

Jennifer Guzman
Senior Director, Medical Affairs Strategy, Helixmith Co., Ltd

Raymond Tesi, MD
President & CEO, INmune Bio

Doug McConnell, MBA
CEO & Co-founder, Safi Biosolutions, Inc.

Anthony Johnson
President/CEO, Kodikaz Therapeutic Solutions, Inc.

Sanjay Kakkar, MD;MPH;MSc
President & CEO, Tranquis Therapeutics

Rachelle Doody
Global Head of Neurodegeneration, Roche

Bill Martin
Global Therapeutic Area Head, Neuroscience, Jansseen Pharmaceutical Companis of Johnson & Johnson

Lisa Ricciardi
CEO, Cognition Therapeutics

John Vandermosten
Security Analyst, Zacks Small Cap Research

Stella Vnook, MBA;RPh
Chief Executive Officer, NAKI Therapeutics

Melissa Bradford-Klug
US President and Chief Business Officer, RareStone Inc.

Timothy Morris
COO/CFO, Humanigen, Inc.

Brian Strem, PhD
President and CEO, Kiora Pharmaceuticals, Inc.

Shankar Musunuri, MBA;PhD
Chief Executive Officer, Ocugen

Mark Suseck
CEO and Director, Vivacitas Oncology Inc

Christopher Trummer, MSc
CEO & Co-Founder, Celeris Therapeutics

John Murphy
Chief Policy Officer, Biotechnology Innovation Organization

Dennis Purcell
Founder, Aisling Capital LLC

Erika Smith
Chief Executive Officer, ReNetX Bio

Pam Traxel
Senior Vice President, American Cancer Society Cancer Action Network, Inc

Samuel Zhang, PhD
Chief Business Officer, NeoImmuneTech Inc

Kristin Stephenson, JD;MHA
Director, Office of Strategy & Alliances - Pediatric Translational Neuroscience Initiative, St. Jude Children's Research Hospital

Greg Frank
Director, Global Public Policy, Merck

Ankit Mahadevia
Chief Executive Officer, Spero Therapeutics, Inc.

Henry Skinner
CEO, AMR Action Fund

David Thomas
Vice President, Industry Research, Biotechnology Innovation Organization

Emily Wheeler
Director, Infectious Disease Policy, Biotechnology Innovation Organization

Bruce Pritchard
Chief Executive Officer, Liminal Biosciences Inc.

J. Robert Coleman, MBA;PhD
CEO, Codagenix Inc.

Mohan Rao
Chief Executive Officer, Expression Therapeutics, Inc.

Robert Foster, PharmD;PhD
CEO, Hepion Pharmaceuticals, Inc.

Gang Zeng, PhD
President and CEO, T-Cure Bioscience, Inc.

Will Chou
CEO, Aruvant Sciences, Inc.

Robert Hoffman
President and CEO, Kintara Therapeutics, Inc.

Susan Angele
Senior Advisor, KPMG LLP

Isaac Bright, MD
CEO, RubrYc Therapeutics, Inc.

Marcel Bucsescu
Director, Certification and Peer Networks, NACD

Byron Loflin
Global Head of Board Engagement, Nasdaq

Anish Bhatnagar
Chief Executive Officer, Soleno Therapeutics, Inc.

Andrew Parker, MBA;PhD
CEO, Step Pharma

David Apelian, MBA;MD;PhD
CEO, BlueSphere Bio, Inc.

Lihua Zheng, JD, PhD
Chief Business Officer, AnHeart Therapeutics

Hans Keirstead
Chairman & CEO, AIVITA Biomedical, Inc.

Sally Allain
Head, JLABS @ Washington, DC, Johnson & Johnson

Vivian Doelling
Vice President, Investments, North Carolina Biotechnology Center

Christopher Jeffers, JD;PhD
Managing Director, Hibiscus Bioventures

Glennis Mehra, PhD
Director, BioLabs @NYULangone

John Temperato
President & CEO, 9 Meters Biopharma, Inc.

Yuqiao Shen, PhD
CEO, AceLink Therapeutics, Inc

Chris Schelling
CEO and Founder, Acer Therapeutics

Dar-Jen Hsieh, PhD
CEO, ACRO Biomedical Co., Ltd.

Klaus Paulini
Senior Director, Aeterna Zentaris Gmbh

Jeffrey Galvin
Chief Executive Officer, American Gene Technologies International Inc.

Pascal Touchon, DVM
President & CEO, Atara Biotherapeutics

Mike Cola
CEO, Avalo Therapeutics

Jordan Lancaster, PhD
Chief Executive Officer, Avery Therapeutics, Inc.

Ilan Sobel
CEO, BioHarvest Sciences

Amir Reichman
CEO, BiondVax Pharmaceuticals Ltd

David Mazzo, PhD
President & CEO, Caladrius Biosciences, Inc

David Slack
President & CEO, Cend Therapeutics Inc.

Charles Nicolette, PhD
Chief Executive Officer, CoImmune, Inc.

Spiro Rombotis, MBA;MPH
President & CEO, Cyclacel Pharmaceuticals, Inc

Christina Coughlin
CEO, CytoImmune Therapeutics, Inc.

Daniel Teper
Co-Founder & CEO, Cytovia Therapeutics, Inc.

Mark Emalfarb
Chief Executive Officer, Dyadic International, Inc.

Vikram Sudarsan, PhD
President and CEO, Engrail Therapeutics, Inc.

Tae Hoon Kim, MBA
Business Development Manager, Enzychem Lifesciences

Chris Baldwin
Deputy CEO & Chief Commercial Officer, Exopharm Ltd

James Sapirstein
Chairman, President and CEO, First Wave BioPharma, Inc.

Hourinaz Behesti
Director of Science, FOXG1 Research Foundation

Rodney Varner
Chairman and CEO, Genprex

David Dodd
Chairman, CEO, GeoVax Labs, Inc

Noam Solomon, PhD
Chief Executive Officer, Immunai

Bob Newman
Chief Business Officer, Immunomic Therapeutics, Inc

Jun Bao, MBA;PhD
President & CEO, Impact Therapeutics

Elaine Haynes
President and CEO, KaloCyte, Inc.

Travis Mickle, PhD
President & CEO, KemPharm, Inc

Natarajan Ranganathan, PhD
Managing Director, Kibow Biotech, Inc

Douglas Doerfler
President & CEO, MaxCyte, Inc.

Sean Hall, MD
CEO, Medlab

Karim Lalji
Chief Executive Officer, Microbion Corporation

Stefan Weber
CEO, Managing Director, Newron Pharmaceuticals, SpA

Denis Dufrane
CEO & Founder, Novadip Biosciences SA

Blake Wise
Chief Executive Officer, Novome Biotechnologies, Inc.

Matt Coffey
CEO, Oncolytics Biotech

Bobby Gaspar, MD;PhD
Chief Executive Officer, Orchard Therapeutics NA

Tom Graney
CEO, OXURION NV

Brett Dines, BPharm;MBA
CEO and Founder, OYE Therapeutics, Inc.

Matthew Price
Executive Vice President & COO, Phosplatin Therapeutics

Pascal Soares
Chief Operating Officer, PHOTOLITEC

Manijeh Goldberg, PhD
CEO, Privo Technologies

Eugene Williams, MBA
Chairman and CEO, ProMIS Neurosciences

Dror Bashan
President & CEO, Protalix Biotherapeutics

Guy Goldberg
Chief Business Officer, Redhill Biopharma

John Ramunas
CEO, Rejuvenation Technologies Inc.

Maggie Cook, MD
CEO, Renovacor

Tony Keating, PhD
CEO, ResApp Health Limited

Thomas Reeves
President & CEO, Ripple Therapeutics Corporation

Anna Kazanchyan, MD
Chief Executive Officer, Saghmos Therapeutics

David Arthur
Chief Executive Officer, Salarius Pharmaceuticals

Frank Gleeson
President, Satellos Bioscience Inc.

Ping Cao
VP, Business Development, Shanghai Henlius Biotech

Lewis Gruber, MS
Chief Executive Officer, SIWA Therapeutics, Inc.

Christopher Schaber, PhD
President & CEO, Soligenix, Inc.

Lynn Durham
CEO & Founder, STALICLA

Hong Wan, PhD
CEO, Tallac Therapeutics, Inc

Roberto Diez
CEO, Telum Therapeutics

Seth Lederman, MD
Chief Executive Officer, TONIX Pharmaceuticals, Inc

Michael Dudley
Co-Founder, CEO, Director, TransCode Therapeutics, Inc.

Michael Christini
CEO, Treovir

Carrie Bourdow
President & CEO, Trevena, Inc.

Dominik Schumacher
CEO, Tubulis - Reimagining Antibody Drug Conjugates

Michael Kokesh, Esq;JD
President & CEO, ViCardia Therapeutics, Inc.

MODERATOR:

John Vandermosten
Security Analyst, Zacks Small Cap Research

2022 Sponsors

BIO DOUBLE HELIX SPONSORS:
• Avantor
• Johnson Johnson
• Amgen
• Bristol Myers Squibb
• Merck

BIO HELIX SPONSORS:
• Genentech
• Lilly
• AbbVie
• Samsung Biologics
• Twist Biopharma
• Pfizer